Literature DB >> 22549303

Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma.

Petri Koivunen1, Leif Bäck, Matti Pukkila, Jussi Laranne, Ilpo Kinnunen, Reidar Grénman, Antti A Mäkitie.   

Abstract

OBJECTIVES/HYPOTHESIS: The first International Union Against Cancer (UICC) TNM classification for aerodigestive malignant mucosal melanoma was not published until 2009, and since then, only a few studies have evaluated the accuracy of this staging system. Our aim was to evaluate the accuracy of this UICC staging system for sinonasal malignant mucosal melanoma (SMMM) in a nationwide survey. STUDY
DESIGN: Retrospective, population-based, multicenter study.
METHODS: The hospital surgical and discharge registries were used to identify the patients. A database including demographic and clinicopathologic variable was created.
RESULTS: Altogether, 50 SMMM patients diagnosed in Finland from 1990 to 2004 were evaluated. Three- and 5-year overall survival rates were 44% and 27%, respectively. Significant differences in overall survival according to T classification (P = .028, log rank) and stage (P = .02, log rank) were found. Tumor extension to the sphenoid sinus had a significant negative impact on survival (n = 11, P = .03, log rank).
CONCLUSIONS: The current UICC staging system for mucosal melanoma provides a useful format for staging SMMMs in clinical settings.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22549303     DOI: 10.1002/lary.23343

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  12 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas.

Authors:  Michelle D Williams
Journal:  Head Neck Pathol       Date:  2017-02-28

2.  Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.

Authors:  Stephanie Flukes; Shivangi Lohia; Christopher A Barker; Jennifer R Cracchiolo; Ian Ganly; Snehal G Patel; Benjamin R Roman; Jatin P Shah; Alexander N Shoushtari; Viviane Tabar; Akash Shah; Marc A Cohen
Journal:  Head Neck       Date:  2020-08-01       Impact factor: 3.147

3.  Multilocular sinonasal malignant melanoma: a poor prognostic subgroup?

Authors:  O Stanimirov Rossi; Domenic Vital; M B Soyka; T N Roth; G F Huber; D Holzmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-05-29       Impact factor: 2.503

Review 4.  Update on primary head and neck mucosal melanoma.

Authors:  Fernando López; Juan P Rodrigo; Antonio Cardesa; Asterios Triantafyllou; Kenneth O Devaney; William M Mendenhall; Missak Haigentz; Primož Strojan; Phillip K Pellitteri; Carol R Bradford; Ashok R Shaha; Jennifer L Hunt; Remco de Bree; Robert P Takes; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

5.  Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.

Authors:  Robert M Samstein; Richard D Carvajal; Michael A Postow; Margaret K Callahan; Alexander N Shoushtari; Snehal G Patel; Nancy Y Lee; Christopher A Barker
Journal:  Head Neck       Date:  2016-04-04       Impact factor: 3.147

6.  Impact of different surgical and postoperative adjuvant treatment modalities on survival of sinonasal malignant melanoma.

Authors:  Xin-Jun Meng; Hua-Fei Ao; Wei-Ting Huang; Fu Chen; Xi-Cai Sun; Jing-Jing Wang; Zhuo-Fu Liu; Wade W Han; Allison N Fry; De-Hui Wang
Journal:  BMC Cancer       Date:  2014-08-23       Impact factor: 4.430

7.  Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013.

Authors:  Gaber Plavc; Jasna But-Hadžić; Aleksandar Aničin; Boštjan Lanišnik; Vojislav Didanović; Primož Strojan
Journal:  Radiat Oncol       Date:  2016-10-14       Impact factor: 3.481

8.  The Prognostic Role of the Surgical Approach and Adjuvant Therapy in Operable Mucosal Melanoma of the Head and Neck.

Authors:  GilJoon Lee; Chung-Hwan Baek; Na Yeon Choi; Man Ki Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-01       Impact factor: 3.372

9.  Comparative study between two different staging systems (AJCC TNM VS BALLANTYNE'S) for mucosal melanomas of the Head & Neck.

Authors:  K Luna-Ortiz; M Aguilar-Romero; V Villavicencio-Valencia; E Zepeda-Castilla; H Vidrio-Morgado; N Peteuil; A Mosqueda-Taylor
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-07-01

10.  Survival benefits from concomitant chemoradiotherapy before radical surgery in stage IVA sinonasal mucosal melanoma?

Authors:  Anna Hafström; Eva Brun; Simon Persson; Johanna Sjövall; Peter Wahlberg; Lennart Greiff
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.